Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

US Preventive Services Task Force.

Ann Intern Med. 2009 Mar 17;150(6):396-404.

PMID:
19293072
2.

Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.

Greving JP, Buskens E, Koffijberg H, Algra A.

Circulation. 2008 Jun 3;117(22):2875-83. doi: 10.1161/CIRCULATIONAHA.107.735340. Epub 2008 May 27.

3.

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG, Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW, Redberg RF, Scott R, Sherif K, Smith SC Jr, Sopko G, Steinhorn RH, Stone NJ, Taubert KA, Todd BA, Urbina E, Wenger NK; Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners.

Circulation. 2007 Mar 20;115(11):1481-501. Epub 2007 Feb 19. Review. No abstract available. Erratum in: Circulation. 2007 Apr 17;115(15):e407.

4.

Further improvements in CHD risk prediction for women.

Blumenthal RS, Michos ED, Nasir K.

JAMA. 2007 Feb 14;297(6):641-3. No abstract available.

PMID:
17299201
5.

Primary prevention of cardiovascular disease: cost-effectiveness comparison.

Franco OH, der Kinderen AJ, De Laet C, Peeters A, Bonneux L.

Int J Technol Assess Health Care. 2007 Winter;23(1):71-9.

PMID:
17234019
6.

Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines.

Nasir K, Michos ED, Blumenthal RS, Raggi P.

J Am Coll Cardiol. 2005 Nov 15;46(10):1931-6. Epub 2005 Oct 20.

7.
8.

Aspirin use for the primary prevention of coronary heart disease in older adults.

Rodondi N, Vittinghoff E, Cornuz J, Butler J, Ding J, Satterfield S, Newman AB, Harris TB, Hulley SB, Bauer DC; Health, Aging, and Body Composition Study research group.

Am J Med. 2005 Nov;118(11):1288.

PMID:
16271917
9.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

10.

Follow-up report on the diagnosis of diabetes mellitus.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Diabetes Care. 2003 Nov;26(11):3160-7. Review. No abstract available.

PMID:
14578255
11.

Multi-Ethnic Study of Atherosclerosis: objectives and design.

Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP.

Am J Epidemiol. 2002 Nov 1;156(9):871-81.

12.

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA.

Circulation. 2002 Jul 16;106(3):388-91. Review. No abstract available.

13.

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale.

U.S. Preventive Services Task Force.

Ann Intern Med. 2002 Jan 15;136(2):157-60.

PMID:
11790071
14.

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group.

JAMA. 2001 Jul 11;286(2):180-7.

PMID:
11448281
15.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.

JAMA. 2001 May 16;285(19):2486-97. No abstract available.

PMID:
11368702
16.

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

de Gaetano G; Collaborative Group of the Primary Prevention Project.

Lancet. 2001 Jan 13;357(9250):89-95. Erratum in: Lancet 2001 Apr 7;357(9262):1134.

PMID:
11197445
17.
18.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S.

Lancet. 1998 Jun 13;351(9118):1755-62.

PMID:
9635947
Items per page

Supplemental Content

Write to the Help Desk